PCN32 RECENT ERYTHROPOIESIS STIMULATING AGENT (ESA) UTILIZATION AND COSTS IN MEDICARE PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY (CRC)
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72122-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)72122-7/fulltext
Section Title :
Section Order :
700
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72122-7&doi=10.1016/S1098-3015(10)72122-7